The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis

Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis

(2014) M. A. Nowell et al.   JOURNAL OF IMMUNOLOGY

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation

(2010) Shigeru Kotake et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: Influence of osteotropic factors

(2008) Steeve Kwan Tat et al.   BONE

Circulating Levels of Inflammatory Markers Predict Change in Bone Mineral Density and Resorption in Older Adults: A Longitudinal Study

(2008) Changhai Ding et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

gp130 signaling in bone cell biology: Multiple roles revealed by analysis of genetically altered mice

(2008) Natalie A. Sims   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts

(2008) C. Sanchez et al.   OSTEOARTHRITIS AND CARTILAGE

The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism

(2007) Inaam A. Nakchbandi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM